BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 27351583)

  • 1. Hepatic fat quantification using the two-point Dixon method and fat color maps based on non-alcoholic fatty liver disease activity score.
    Hayashi T; Saitoh S; Takahashi J; Tsuji Y; Ikeda K; Kobayashi M; Kawamura Y; Fujii T; Inoue M; Miyati T; Kumada H
    Hepatol Res; 2017 Apr; 47(5):455-464. PubMed ID: 27351583
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Feasibility of a three-step magnetic resonance imaging approach for the assessment of hepatic steatosis in an asymptomatic study population.
    Hetterich H; Bayerl C; Peters A; Heier M; Linkohr B; Meisinger C; Auweter S; Kannengießer SA; Kramer H; Ertl-Wagner B; Bamberg F
    Eur Radiol; 2016 Jun; 26(6):1895-904. PubMed ID: 26340812
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Quantitative MRI for hepatic fat fraction and T2* measurement in pediatric patients with non-alcoholic fatty liver disease.
    Deng J; Fishbein MH; Rigsby CK; Zhang G; Schoeneman SE; Donaldson JS
    Pediatr Radiol; 2014 Nov; 44(11):1379-87. PubMed ID: 24840769
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Validation of water-fat MRI and proton MRS in assessment of hepatic fat and the heterogeneous distribution of hepatic fat and iron in subjects with non-alcoholic fatty liver disease.
    Hui SCN; So HK; Chan DFY; Wong SKH; Yeung DKW; Ng EKW; Chu WCW
    Eur J Radiol; 2018 Oct; 107():7-13. PubMed ID: 30292275
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hepatic fat quantification: a prospective comparison of magnetic resonance spectroscopy and analysis methods for chemical-shift gradient echo magnetic resonance imaging with histologic assessment as the reference standard.
    Kang BK; Yu ES; Lee SS; Lee Y; Kim N; Sirlin CB; Cho EY; Yeom SK; Byun JH; Park SH; Lee MG
    Invest Radiol; 2012 Jun; 47(6):368-75. PubMed ID: 22543969
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Two-point Dixon and six-point Dixon magnetic resonance techniques in the detection, quantification and grading of hepatic steatosis.
    Elfaal M; Supersad A; Ferguson C; Locas S; Manolea F; Wilson MP; Sam M; Tu W; Low G
    World J Radiol; 2023 Oct; 15(10):293-303. PubMed ID: 37969136
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A comparison of liver fat content as determined by magnetic resonance imaging-proton density fat fraction and MRS versus liver histology in non-alcoholic fatty liver disease.
    Idilman IS; Keskin O; Celik A; Savas B; Elhan AH; Idilman R; Karcaaltincaba M
    Acta Radiol; 2016 Mar; 57(3):271-8. PubMed ID: 25855666
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Liver fat quantification: Comparison of dual-echo and triple-echo chemical shift MRI to MR spectroscopy.
    Satkunasingham J; Besa C; Bane O; Shah A; de Oliveira A; Gilson WD; Kannengiesser S; Taouli B
    Eur J Radiol; 2015 Aug; 84(8):1452-1458. PubMed ID: 26047820
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Three segments sampling strategy for the assessment of liver steatosis using magnetic resonance imaging proton density fat fraction.
    Kim A; Kim M; Lee CM; Kang BK; Jun DW
    Eur J Radiol; 2023 Feb; 159():110653. PubMed ID: 36563563
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Simultaneous MR quantification of hepatic fat content, fatty acid composition, transverse relaxation time and magnetic susceptibility for the diagnosis of non-alcoholic steatohepatitis.
    Leporq B; Lambert SA; Ronot M; Vilgrain V; Van Beers BE
    NMR Biomed; 2017 Oct; 30(10):. PubMed ID: 28678410
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sitagliptin vs. placebo for non-alcoholic fatty liver disease: A randomized controlled trial.
    Cui J; Philo L; Nguyen P; Hofflich H; Hernandez C; Bettencourt R; Richards L; Salotti J; Bhatt A; Hooker J; Haufe W; Hooker C; Brenner DA; Sirlin CB; Loomba R
    J Hepatol; 2016 Aug; 65(2):369-76. PubMed ID: 27151177
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hepatic fat quantification of magnetic resonance imaging whole-liver segmentation for assessing the severity of nonalcoholic fatty liver disease: comparison with a region of interest sampling method.
    Zhang QH; Zhao Y; Tian SF; Xie LH; Chen LH; Chen AL; Wang N; Song QW; Zhang HN; Xie LZ; Shen ZW; Liu AL
    Quant Imaging Med Surg; 2021 Jul; 11(7):2933-2942. PubMed ID: 34249624
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Accuracy of multi-echo Dixon sequence in quantification of hepatic steatosis in Chinese children and adolescents.
    Zhao YZ; Gan YG; Zhou JL; Liu JQ; Cao WG; Cheng SM; Bai DM; Wang MZ; Gao FQ; Zhou SM
    World J Gastroenterol; 2019 Mar; 25(12):1513-1523. PubMed ID: 30948914
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Accuracy of Multi-echo Dixon Sequence in Quantification of Hepatic Steatosis.
    Yurdaisik I; Nurili F
    Cureus; 2020 Feb; 12(2):e7103. PubMed ID: 32231898
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MR Quantification of the Fatty Fraction from T2*-corrected Dixon Fat/Water Separation Volume-interpolated Breathhold Examination (VIBE) in the Assessment of Muscle Atrophy in Rotator Cuff Tears.
    Lee YH; Kim S; Lim D; Song HT; Suh JS
    Acad Radiol; 2015 Jul; 22(7):909-17. PubMed ID: 24709378
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Quantitative susceptibility mapping in combination with water-fat separation for simultaneous liver iron and fat fraction quantification.
    Lin H; Wei H; He N; Fu C; Cheng S; Shen J; Wang B; Yan X; Liu C; Yan F
    Eur Radiol; 2018 Aug; 28(8):3494-3504. PubMed ID: 29470640
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Quantification of renal steatosis in type II diabetes mellitus using dixon-based MRI.
    Yokoo T; Clark HR; Pedrosa I; Yuan Q; Dimitrov I; Zhang Y; Lingvay I; Beg MS; Bobulescu IA
    J Magn Reson Imaging; 2016 Nov; 44(5):1312-1319. PubMed ID: 27007212
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Feasibility of modified Dixon MRI techniques for hepatic fat quantification in hepatic disorders: validation with MRS and histology.
    Kang BK; Kim M; Song SY; Jun DW; Jang K
    Br J Radiol; 2018 Sep; 91(1089):20170378. PubMed ID: 29022777
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Longitudinal correlations between MRE, MRI-PDFF, and liver histology in patients with non-alcoholic steatohepatitis: Analysis of data from a phase II trial of selonsertib.
    Jayakumar S; Middleton MS; Lawitz EJ; Mantry PS; Caldwell SH; Arnold H; Mae Diehl A; Ghalib R; Elkhashab M; Abdelmalek MF; Kowdley KV; Stephen Djedjos C; Xu R; Han L; Mani Subramanian G; Myers RP; Goodman ZD; Afdhal NH; Charlton MR; Sirlin CB; Loomba R
    J Hepatol; 2019 Jan; 70(1):133-141. PubMed ID: 30291868
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Assessment of Nonalcoholic Fatty Liver Disease Progression in Children Using Magnetic Resonance Imaging.
    Mouzaki M; Trout AT; Arce-Clachar AC; Bramlage K; Kuhnell P; Dillman JR; Xanthakos S
    J Pediatr; 2018 Oct; 201():86-92. PubMed ID: 30041934
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.